91 related articles for article (PubMed ID: 1693270)
1. Specific binding of plasminogen to vitronectin. Evidence for a modulatory role of vitronectin on fibrin(ogen)-induced plasmin formation by tissue plasminogen activator.
Preissner KT
Biochem Biophys Res Commun; 1990 May; 168(3):966-71. PubMed ID: 1693270
[TBL] [Abstract][Full Text] [Related]
2. Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation.
Kost C; Stüber W; Ehrlich HJ; Pannekoek H; Preissner KT
J Biol Chem; 1992 Jun; 267(17):12098-105. PubMed ID: 1376317
[TBL] [Abstract][Full Text] [Related]
3. Limited plasmin proteolysis of vitronectin. Characterization of the adhesion protein as morpho-regulatory and angiostatin-binding factor.
Kost C; Benner K; Stockmann A; Linder D; Preissner KT
Eur J Biochem; 1996 Mar; 236(2):682-8. PubMed ID: 8612645
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
Liu JN; Gurewich V
J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
[TBL] [Abstract][Full Text] [Related]
5. Limited proteolysis of vitronectin by plasmin destroys heparin binding activity.
Sane DC; Moser TL; Greenberg CS
Thromb Haemost; 1991 Sep; 66(3):310-4. PubMed ID: 1720904
[TBL] [Abstract][Full Text] [Related]
6. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
[TBL] [Abstract][Full Text] [Related]
7. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells.
Moser TL; Enghild JJ; Pizzo SV; Stack MS
Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):867-73. PubMed ID: 7537960
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
Rouy D; Anglés-Cano E
Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
[TBL] [Abstract][Full Text] [Related]
9. Differences in effects of fibrin(ogen) fragments on the activation of 1-glu-plasminogen and 442-val-plasminogen by tissue-type plasminogen activator.
Verheijen JH; Nieuwenhuizen W; Traas DW; Chang GT; Hoegee E
Thromb Res; 1983 Oct; 32(1):87-92. PubMed ID: 6229056
[TBL] [Abstract][Full Text] [Related]
10. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
Suenson E; Thorsen S
Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
[TBL] [Abstract][Full Text] [Related]
11. Fibrin and plasminogen structures essential to stimulation of plasmin formation by tissue-type plasminogen activator.
Suenson E; Petersen LC
Biochim Biophys Acta; 1986 Apr; 870(3):510-9. PubMed ID: 2938632
[TBL] [Abstract][Full Text] [Related]
12. Aβ delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin.
Zamolodchikov D; Strickland S
Blood; 2012 Apr; 119(14):3342-51. PubMed ID: 22238323
[TBL] [Abstract][Full Text] [Related]
13. [The effect of kringles K1-3, K4 and K5 on lysis of fibrin clots caused by the activation of Glu- and Lys-plasminogen by a tissue activator].
Taran LD; Makogonenko EM
Ukr Biokhim Zh (1978); 1989; 61(4):31-6. PubMed ID: 2511651
[TBL] [Abstract][Full Text] [Related]
14. Denatured proteins as cofactors for plasminogen activation.
Machovich R; Owen WG
Arch Biochem Biophys; 1997 Aug; 344(2):343-9. PubMed ID: 9264548
[TBL] [Abstract][Full Text] [Related]
15. [The effect of heparin on the proteolytic and fibrinolytic activity on plasmin(ogen) and fibrin clot lysis].
Kudinov SA; Kolesnik LA; Makogonenko EM; Shuliakovskaia TA
Biokhimiia; 1989 Nov; 54(11):1881-7. PubMed ID: 2534055
[TBL] [Abstract][Full Text] [Related]
16. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II).
Kamijyo Y; Hirota-Kawadobora M; Yamauchi K; Terasawa F; Honda T; Ikeya M; Okumura N
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):726-32. PubMed ID: 19809304
[TBL] [Abstract][Full Text] [Related]
17. Tissue-type plasminogen activator-mediated activation of plasminogen on the surface of group A, C, and G streptococci.
Kuusela P; Ullberg M; Saksela O; Kronvall G
Infect Immun; 1992 Jan; 60(1):196-201. PubMed ID: 1370273
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
Jiao J; Yu M; Ru B
Biochim Biophys Acta; 2001 Apr; 1546(2):399-405. PubMed ID: 11295444
[TBL] [Abstract][Full Text] [Related]
19. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
[TBL] [Abstract][Full Text] [Related]
20. Reexamination of the extent of the activation of Lys78 plasminogen by tissue plasminogen activator in the presence of polymerized fibrin.
Urano T; Takada Y; Ihara H; Takada A
Haemostasis; 1996; 26(4):220-7. PubMed ID: 8872134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
